Ryan BM - Search Results

1

A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.

Veerappan SG, Healy M, Walsh B, O'Morain CA, Daly JS, Ryan BM. Veerappan SG, et al. Among authors: ryan bm. Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1335-44. doi: 10.1097/MEG.0000000000000719. Eur J Gastroenterol Hepatol. 2016. PMID: 27508327 Clinical Trial.

2

Safety of infliximab in 10 years of clinical practice.

O'Donnell S, Murphy S, Anwar MM, O'Sullivan M, Breslin N, O'Connor HJ, Ryan BM, O'Morain CA. O'Donnell S, et al. Among authors: ryan bm. Eur J Gastroenterol Hepatol. 2011 Jul;23(7):603-6. doi: 10.1097/MEG.0b013e3283479125. Eur J Gastroenterol Hepatol. 2011. PMID: 21602689

3

The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.

O'Donnell S, O'Sullivan M, O'Morain CA, Ryan BM. O'Donnell S, et al. Among authors: ryan bm. Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1464-9. doi: 10.1097/MEG.0b013e328365a364. Eur J Gastroenterol Hepatol. 2013. PMID: 24047859

4

Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.

Veerappan SG, Healy M, Walsh BJ, O'Morain CA, Daly JS, Ryan BM. Veerappan SG, et al. Among authors: ryan bm. Dig Dis Sci. 2015 Jul;60(7):2119-29. doi: 10.1007/s10620-015-3606-z. Epub 2015 Mar 3. Dig Dis Sci. 2015. PMID: 25732718 Clinical Trial.

5

The future of nanomedicine in optimising the treatment of inflammatory bowel disease.

Mohan LJ, Daly JS, Ryan BM, Ramtoola Z. Mohan LJ, et al. Among authors: ryan bm. Scand J Gastroenterol. 2019 Jan;54(1):18-26. doi: 10.1080/00365521.2018.1563805. Epub 2019 Jan 24. Scand J Gastroenterol. 2019. PMID: 30678499 Review.

6

Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease.

Veerappan SG, O'Morain CA, Daly JS, Ryan BM. Veerappan SG, et al. Among authors: ryan bm. Aliment Pharmacol Ther. 2011 Jun;33(12):1261-72. doi: 10.1111/j.1365-2036.2011.04667.x. Epub 2011 Apr 26. Aliment Pharmacol Ther. 2011. PMID: 21521250 Free article. Review.

7

Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.

O'connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, O'connor H, Qasim A, Breslin N, O'moráin C. O'connor A, et al. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1123-7. doi: 10.1097/MEG.0b013e328338e43d. Eur J Gastroenterol Hepatol. 2010. PMID: 20354442

8

Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis.

Veerappan SG, Kennedy M, O'Morain CA, Ryan BM. Veerappan SG, et al. Among authors: ryan bm. Eur J Gastroenterol Hepatol. 2008 Jun;20(6):588-9. doi: 10.1097/MEG.0b013e3282f376ac. Eur J Gastroenterol Hepatol. 2008. PMID: 18467922 No abstract available.

9

Eosinophilic oesophagitis: an Irish experience.

O'Donnell S, Kelly OB, Breslin N, Ryan BM, O'Connor HJ, Swan N, O'Morain CA. O'Donnell S, et al. Among authors: ryan bm. Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1116-21. doi: 10.1097/MEG.0b013e32834a5870. Eur J Gastroenterol Hepatol. 2011. PMID: 21946074

10

Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease.

Judge C, McGettigan N, Ryan T, Hazel K, Singh P, Parihar V, Stack R, O'Connor A, Dunne C, Cullen G, Egan L, Harewood G, MacCarthy F, McKiernan S, Mulcahy H, Murray F, Patchett S, Sheridan J, Cheriyan D, Farrell R, Keohane J, Kelly O, McNamara D, Ryan B, O'Morain C, Sengupta S, O'Toole A, Buckley M, McCarthy J, Doherty G, Kevans D, Slattery E. Judge C, et al. Scand J Gastroenterol. 2020 Jul;55(7):786-794. doi: 10.1080/00365521.2020.1779340. Epub 2020 Jun 16. Scand J Gastroenterol. 2020. PMID: 32544012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page